Peer-reviewed evidence

Peer-reviewed evidence

Sophisticated plant extract inhibits in vitro the growth and biofilm formation of Staphylococcus pseudintermedius isolated from canine skin and ear infections

In vitro evaluation of WECMEP 16P576 against 43 clinical Staphylococcus pseudintermedius isolates from canine skin and ear infections. The extract inhibited growth in 40/43 strains at 0.5 g/L and achieved more than 90% biofilm inhibition (average), including against antibiotic-resistant isolates. Results were reproducible across plant-source variations, supporting further investigation as a topical approach for canine superficial pyoderma and otitis externa.

Peer-reviewed evidence poster preview

43canine isolates tested

40/43growth inhibition at 500µg/mL(43/43 at 0.2% w/v)

More than
90%
biofilm inhibition (average)

Why this matters for veterinarians

Effective against antibiotic multiresistant clinical strains

Demonstrated activity against 43 clinical Staphylococcus pseudintermedius isolates from skin and ear infections.

Potent biofilm control

Achieved more than 90% biofilm inhibition (average), including against antibiotic-resistant isolates.

Plant-based innovation

Reproducible results across plant-source variations, supporting a novel topical approach.

i

This study supports the potential of WECMEP 16P576 as a plant-based option for the management of canine superficial pyoderma and otitis externa.